VTRS FY 2025 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$17B

FY 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$14.3B-3.0% YoY

Gross Profit

$5.0B35.1% margin

Operating Income

-$2.7B-18.6% margin

Net Income

-$3.5B-24.6% margin

EPS (Diluted)

$-3.00

Cash Flow

Operating Cash Flow

$2.3B

Free Cash Flow

$1.9B

Stock-Based Comp.

$178M

Balance Sheet

Total Assets

$37.2B

Total Liabilities

$22.5B

Stockholders' Equity

$14.7B

Cash & Equivalents

$1.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14.3B	$14.7B	-3.0%
Gross Profit	$5.0B	$5.6B	-10.8%
Operating Income	-$2.7B	$10M	-26467.3%
Net Income	-$3.5B	-$634M	-454.2%